Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 11 , ISSUE 4 ( October-December, 2022 ) > List of Articles

Original Article

Pulmonary Hypertension in Posttubercular Pulmonary Fibrosis: A Prospective Study from Western Himalayas

Sanjay Kumar, R. S. Negi, Sunil Sharma, Arvind Kandoria, Trilok Chand Guleria

Keywords : Echocardiography, fibrosis, hypertension, posttubercular, pulmonary

Citation Information : Kumar S, Negi RS, Sharma S, Kandoria A, Guleria TC. Pulmonary Hypertension in Posttubercular Pulmonary Fibrosis: A Prospective Study from Western Himalayas. Indian J Respir Care 2022; 11 (4):349-352.

DOI: 10.4103/ijrc.ijrc_83_22

License: CC BY-NC-SA 4.0

Published Online: 01-12-2022

Copyright Statement:  Copyright © 2022; Indian Journal of Respiratory Care.


Introduction: Pulmonary tuberculosis (PTB) has been linked to a high rate of morbidity and mortality. Studies that assessed the impact of treated PTB as a cause of disability have focused on impairment of pulmonary function. Pulmonary hypertension (PH) must be assessed in patients with posttubercular pulmonary fibrosis. The goal of this study was to use Doppler echocardiography to determine the prevalence of PH in individuals with posttubercular pulmonary fibrosis. Materials and Methods: It was a prospective cross-sectional hospital-based study carried out over a period of 1 year. Patients having posttubercular pulmonary fibrosis were enrolled after fulfilling the inclusion and exclusion criteria, further evaluated by Doppler echocardiography for PH. Results: A total of 80 patients with the most common age group of 31-40 years and female predominance were involved in the study. Dyspnea was the most common symptom being reported by 100% of the patients, followed by cough (32.5%), hemoptysis (22.5%), chest pain (10%), and syncope (2.5%). Tricuspid regurgitation velocity was found <2.8 m/s in 52.5%, between 2.9 and 3.4 m/s in 30% and >3.4 m/s in 17.5% patients. In our study, mild PH was present in 25%, moderate PH in 6.3%, and severe PH in 16.3% of patients with an insignificant P = 0.200. Conclusions: Tuberculosis may have a causal association with PH. The results of the present study suggest that 2D echocardiography is a useful tool in diagnosing pulmonary hypertension in posttubercular pulmonary fibrosis.

  1. WHO. Global Tuberculosis Report 2017. Licence: CC BY-NCSA 3.0 IGO. Geneva, Switzerland: World Health Organization; 2017.
  2. Snider GL, Doctor L, Demas TA, Shaw AR. Obstructive airway disease in patients with treated pulmonary tuberculosis. Am Rev Respir Dis 1971;103:625-40.
  3. Birath G, Caro J, Malmberg R, Simonsson BG. Airways obstruction in pulmonary tuberculosis. Scand J Respir Dis 1966;47:27-36.
  4. Pasipanodya JG, Miller TL, Vecino M, Munguia G, Garmon R, Bae S, et al. Pulmonary impairment after tuberculosis. Chest 2007;131:1817-24.
  5. Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, et al. Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol 2013;62 25 Suppl: D109-16.
  6. Simpson DG, Uschner M, Mc Clement J. Respiratory function in pulmonary tuberculosis. Am Rev Respir Dis 1963;87:1-16.
  7. Shorr AF, Wainright JL, Cors CS, Lettieri CJ, Nathan SD. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 2007;30:715-21.
  8. Nathan SD, Shlobin OA, Weir N, Ahmad S, Kaldjob JM, Battle E, et al. Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest 2011;140:221-9.
  9. Rivera-Lebron BN, Forfia PR, Kreider M, Lee JC, Holmes JH, Kawut SM. Echocardiographic and hemodynamic predictors of mortality in idiopathic pulmonary fibrosis. Chest 2013;144:564-70.
  10. Naeije R. Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:20-2.
  11. Zisman DA, Karlamangla AS, Ross DJ, Keane MP, Belperio JA, Saggar R, et al. High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 2007;132:773-9.
  12. Patel NM, Lederer DJ, Borczuk AC, Kawut SM. Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 2007;132:998-1006.
  13. Vakil RJ. Cardiovascular diseases in India. Am J Cardiol 1962;10:380-9.
  14. Janda S, Shahidi N, Gin K, Swiston J. Diagnostic accuracy of echocardiography for pulmonary hypertension: A systematic review and meta-analysis. Heart 2011;97:612-22.
  15. Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003;167:735-40.
  16. Kapoor SC. Pathogenesis of cor pulmonale in pulmonary tuberculosis. Indian J Tuberc 1986;33:167-70.
  17. Ahmed AE, Ibrahim AS, Elshafie SM. Pulmonary hypertension in patients with treated pulmonary tuberculosis: Analysis of 14 consecutive cases. Clin Med Insights Circ Respir Pulm Med 2011;5:1-5.
  18. Marjani M, Baghaei P, Malekmohammad M, Tabarsi P, Sharif-Kashani B, Behzadnia N, et al. Effect of pulmonary hypertension on outcome of pulmonary tuberculosis. Braz J Infect Dis 2014;18:487-90.
  19. Patel V, Khaped K, Solanki B, Patel A, Rathod H, Patel J. Profile of pulmonary hypertension patients coming to Civil Hospital, Ahmedabad. Int J Res Med 2013;2:94-7.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.